30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

d'Entremont, Kenneth

Track

Insider profile

Performance

Overall performance
4.3
Performance over holding periods
4.3
30 days 90 days 120 days
Average return 22% 8.2% 15.1%
Success rate 86% 68% 82%
Transactions
8 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
d'Entremont, Kenneth's trades of Medexus Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-24 2024-09-19
B Purchase
12,314 +37.3%
379.57
CA$478,963 		12,314 +37.3% 379.57 CA$478,963
2024-06-28 2024-06-28
B Purchase
60,014 -37.1%
144.25
CA$2,398,924 		60,014 -37.1% 144.25 CA$2,398,924
2024-06-28 2024-06-27
B Purchase
57,890 +22.0%
65.95
CA$3,453,159 		57,890 +22.0% 65.95 CA$3,453,159
2023-06-30 2023-06-29
B Purchase
3,800 +0.6%
1.67
CA$6,346 		3,800 +0.6% 1.67 CA$6,346
2023-06-26 2023-06-23
B Purchase
15,000 +2.4%
1.42
CA$21,300 		15,000 +2.4% 1.42 CA$21,300
2022-12-14 2022-12-13
S Sale
1,200 -0.2%
1.92
CA$2,304 		1,200 -0.2% 1.92 CA$2,304
2022-12-22 2022-12-12
S Sale
4,000 -0.7%
1.91
CA$7,640 		4,000 -0.7% 1.91 CA$7,640
2022-09-21 2022-09-21
B Purchase
10,000 +1.7%
1.19
CA$11,900 		10,000 +1.7% 1.19 CA$11,900